$HALB Halberd Corporation CEO Update Letter – &
Post# of 10140
![](/assets/46931549/no_avatar_available_thumb.jpg)
* Secured license to two issued patents on an extracorporeal treatment process, previously held by Premier Biomedical.
* Established Coronavirus as clinical target for extracorporeal patent application.
* Secured license to three provisional patent applications for Coronavirus work.
* Secured required non-dilutive funding to start work at a research facility.
http://www.thestreetnow.com/spotlight/halb/
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)